Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$21.48 - $27.71 $2.08 Million - $2.69 Million
-97,035 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$21.07 - $29.31 $233,687 - $325,077
11,091 Added 12.9%
97,035 $2.21 Million
Q4 2018

Feb 12, 2019

BUY
$22.4 - $35.39 $1.93 Million - $3.04 Million
85,944 New
85,944 $2.58 Million

Others Institutions Holding CRNX

About Crinetics Pharmaceuticals, Inc.


  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $3.18B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Emory University Portfolio

Follow Emory University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

News

Stay updated on Emory University with notifications on news.